These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30359453)

  • 1. The effects of oral contraceptive usage on thrombin generation and activated protein C resistance in Saudi women, with a possible impact of the body mass index.
    Mohamed ABO; Kelchtermans H; Konings J; van Daal J; Al Marzouki A; Harakeh S; de Laat B
    PLoS One; 2018; 13(10):e0206376. PubMed ID: 30359453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Contraceptive Types in Relation to ABO Blood Groups Among Saudi Women of Different Reproductive Age Groups and Impact on Venous Thromboembolism.
    Mohamed ABO; Al-Ama N; Al Kreathy H; Ahmed KHB; Al Amri T; Harakeh S; Mousa SA; De Laat B
    Clin Appl Thromb Hemost; 2020; 26():1076029620966051. PubMed ID: 33112684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography.
    Tchaikovski SN; van Vliet HA; Thomassen MC; Bertina RM; Rosendaal FR; Sandset PM; Helmerhorst FM; Tans G; Rosing J
    Thromb Haemost; 2007 Dec; 98(6):1350-6. PubMed ID: 18064335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oral contraceptives on hemostasis and thrombosis.
    Rosing J; Tans G
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S375-82. PubMed ID: 10368524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of calibrated automated thrombinography +/- thrombomodulin to recognise the prothrombotic phenotype.
    Dargaud Y; Trzeciak MC; Bordet JC; Ninet J; Negrier C
    Thromb Haemost; 2006 Nov; 96(5):562-7. PubMed ID: 17080211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
    Rosing J; Middeldorp S; Curvers J; Christella M; Thomassen LG; Nicolaes GA; Meijers JC; Bouma BN; Büller HR; Prins MH; Tans G
    Lancet; 1999 Dec; 354(9195):2036-40. PubMed ID: 10636369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased thrombin generation in women with polycystic ovary syndrome: A pilot study on the effect of metformin and oral contraceptives.
    Glintborg D; Sidelmann JJ; Altinok ML; Mumm H; Andersen M
    Metabolism; 2015 Oct; 64(10):1272-8. PubMed ID: 26194691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of acquired activated protein C resistance with the FibWave and comparison with the ETP-based APC resistance.
    Evrard J; Morimont L; Didembourg M; Haguet H; Siriez R; Dogné JM; Douxfils J
    Int J Lab Hematol; 2021 Aug; 43(4):802-812. PubMed ID: 33314736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to activated protein C in healthy women taking oral contraceptives.
    Olivieri O; Friso S; Manzato F; Guella A; Bernardi F; Lunghi B; Girelli D; Azzini M; Brocco G; Russo C
    Br J Haematol; 1995 Oct; 91(2):465-70. PubMed ID: 8547095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation.
    Ammollo CT; Semeraro F; Xu J; Esmon NL; Esmon CT
    J Thromb Haemost; 2011 Sep; 9(9):1795-803. PubMed ID: 21711444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives.
    Rosing J; Tans G; Nicolaes GA; Thomassen MC; van Oerle R; van der Ploeg PM; Heijnen P; Hamulyak K; Hemker HC
    Br J Haematol; 1997 Apr; 97(1):233-8. PubMed ID: 9136971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oral contraceptives on the anticoagulant activity of protein S in plasma.
    Koenen RR; Christella M; Thomassen LG; Tans G; Rosing J; Hackeng TM
    Thromb Haemost; 2005 May; 93(5):853-9. PubMed ID: 15886799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombomodulin alfa attenuates the procoagulant effect and cytotoxicity of extracellular histones through the promotion of protein C activation.
    Osada K; Minami T; Arioka T; Sakai T; Tawara S; Kawasaki K; Fareed J; Matsuzaki O
    Thromb Res; 2017 Dec; 160():51-57. PubMed ID: 29101790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives.
    Alhenc-Gelas M; Plu-Bureau G; Guillonneau S; Kirzin JM; Aiach M; Ochat N; Scarabin PY
    J Thromb Haemost; 2004 Sep; 2(9):1594-600. PubMed ID: 15333036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis.
    Sinegre T; Duron C; Lecompte T; Pereira B; Massoulier S; Lamblin G; Abergel A; Lebreton A
    J Thromb Haemost; 2018 Jun; 16(6):1132-1140. PubMed ID: 29577605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombin-independent thrombin inhibitors, but not direct factor Xa inhibitors, enhance thrombin generation in plasma through inhibition of thrombin-thrombomodulin-protein C system.
    Furugohri T; Sugiyama N; Morishima Y; Shibano T
    Thromb Haemost; 2011 Dec; 106(6):1076-83. PubMed ID: 22012070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normalized activated protein C ratio itself not associated with increased risk of venous thromboembolism.
    Heinemann LA; Assmann A; Spannagl M; Schramm W; Dick A; Kluft C; de Maat MP
    Contraception; 1998 Nov; 58(5):321-2. PubMed ID: 9883389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombomodulin accelerates activated protein C production and inhibits thrombin generation in the plasma of disseminated intravascular coagulation patients.
    Wada H; Sakakura M; Kushiya F; Nisikawa M; Onishi K; Nakatani K; Shiku H; Nobori T
    Blood Coagul Fibrinolysis; 2005 Jan; 16(1):17-24. PubMed ID: 15650541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kallikrein augments the anticoagulant function of the protein C system in thrombin generation.
    Wan J; Vadaq N; Konings J; Jaeger M; Kumar V; de Laat B; Joosten L; Netea MG; van der Ven AJ; de Groot PG; de Mast Q; Roest M
    J Thromb Haemost; 2022 Jan; 20(1):48-57. PubMed ID: 34532976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hormone-associated resistance to activated protein C on the thrombotic potential of oral contraceptives: a prospective observational study.
    Rühl H; Schröder L; Müller J; Sukhitashvili S; Welz J; Kuhn WC; Oldenburg J; Rudlowski C; Pötzsch B
    PLoS One; 2014; 9(8):e105007. PubMed ID: 25121606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.